Holy Stone Healthcare Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Holy Stone Healthcare Co Ltd with three other
companies in this sector in TAIWAN :
General Biological Corporation
sales of 239.65 million Taiwanese Dollars [US$8.16 million]
Taiwan Advance Bio-Pharmaceutical Inc
(205.80 million Taiwanese Dollars [US$7.01 million]
(305.69 million Taiwanese Dollars [US$10.41 million]
of which 100%
was Pharmaceutical Development).
During the year ended December of 2019, sales at
Holy Stone Healthcare Co Ltd were 204.16 million Taiwanese Dollars (US$6.95 million).
increase of 18.1%
versus 2018, when the company's sales were 172.84 million Taiwanese Dollars .
This was the fifth consecutive year of sales increases at Holy Stone Healthcare Co Ltd
(and since 2014, sales have increased a total of 66%).